"Vismodegib" Pronounce,Meaning And Examples

"Vismodegib" Meaning

Vismodegib is a medication used to treat a type of skin cancer called basal cell carcinoma (BCC). It is a hedgehog pathway inhibitor, which means it blocks the signaling pathways involved in the growth of basal cell carcinoma cells.

Vismodegib works by binding to the smoothened receptor, which is a key player in the hedgehog signaling pathway. By binding to this receptor, vismodegib prevents the pathway from sending signals that promote the growth of basal cell carcinoma cells. This can slow down or stop the growth of the cancer.

Vismodegib is typically used to treat advanced forms of basal cell carcinoma, such as locally advanced BCC or metastatic BCC. It has also been used in patients who do not respond to other treatments or who have specific types of BCC that are resistant to certain other medications.

"Vismodegib" Examples

Examples of Vismodegib

In Medical Context

Vismodegib is a prescription medication used to treat advanced cancer, specifically in patients with locally advanced basosquamous carcinoma, locally advanced or metastatic basal cell carcinoma, and adult patients with metastatic low-grade adnexal skin carcinomas.
The medication functions by blocking the Hedgehog signaling pathway, which is crucial for tumor growth.
Results from studies have shown the effectiveness of vismodegib in treating these types of cancers, though potential side effects are common due to its mechanism affecting vital bodily systems.

In Pharmaceutical Context

Vismodegib is manufactured by Genentech, Inc. and is available in capsule form.
The dosage and administration guidelines for vismodegib require careful consideration due to its potential to cause significant side effects, including muscle spasms, alterations to the senses of taste and smell, and hair loss.
Patients undergoing chemotherapy often experience a range of side effects due to the toxic effects of the drugs on body systems.

In Clinical Study Context

Research studies on vismodegib have investigated its efficacy in treating various types of cancer, including its ability to initiate tumor regression.
Clinical trials for the medication have provided valuable insights into its potential benefits and adverse effects, such as severe visual field defects and changes to cognitive function.
These studies have also explored optimal dosing regimens to best manage side effects while maximizing the medication's effectiveness in gender activation sequencing graphs.

In Public Context

Vismodegib has been widely covered in the media for its novel mode of action as an Hh inhibitor.
Pharmaceutical companies have since developed similar drugs to target this pathway in other types of cancer, recognizing its potential as a universal cancer therapeutic.
These advancements in the field have brought hope to patients with previously serious cancers.